Associate Professor, Department of Pharmacy Practice & Science
Dr. Aaron Cook
Dr. Cook received his Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy and subsequently completed a pharmacy practice and a critical care specialty residency at the University of Kentucky Chandler Medical Center. Dr. Cook is active in his clinical practice in neurocritical care at UK Hospital where he is also the Neuroscience-Pulmonary/Critical Care clinical coordinator. He is also active in precepting both pharmacy residents and students on the neurosurgery service.
Dr. Cook is the co-chair of the Neurocritical Care Society pharmacy research committee, incoming chair of the pharmacy committee, and the co-chair of the writing group for the Treatment of Elevated Intracranial Pressure guidelines.
Neurocritical care, inflammation in critical illness, metabolic and pharmacokinetic alterations in neurocritical care
Cook Aaron M. (2017). Status Epilepticus.American College of Clinical Pharmacy,
Thompson Bastin Melissa L, Cook Aaron M, Flannery Alexander H. (2017). Use of simulation training to prepare pharmacy residents for medical emergencies.Amer J Health-System Pharmacy, 74(6), 424-429.
May Casey, Smetana Keaton, Cook Aaron M. (2017). Osmotherapy agents.Oxford University Press ,
Human T, Cook Aaron M, Anger B, Bledsoe K, Castle A, Deen D, Gibbs H, Lesch C, Liang N, McAllen K, Morrison C, Parker D, Rowe A S, Rhoney D, Sangha K, Santayana E, Taylor S, Tesoro E, Brophy G. (2017). Treatment of hyponatremia in patients with acute neurological injury.Neurocritical Care,
Nguyen V-H, Liang Norah, Cook Aaron M. (2017). Antiepileptic agents for seizure prophylaxis and treatment.Rutgers University Press ,
Ruf K M, Magnuson Barbara L, Hatton Jimmi, Cook Aaron M. (2017). Neurological impairment.
Smetana K S, Cook Aaron M, Thompson Bastin Melissa L, Oyler Douglas R. (2016). Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.Journal of critical care, 36, 116-124.
Pileggi D J, Cook Aaron M. (2016). Neuroleptic malignant syndrome review: Focus on treatment and re-challenge.Annals of Pharmacotherapy,